PT4144834T - Método para isolar células trofoblásticas placentárias de células esfoliadas do colo do útero de uma mulher grávida - Google Patents

Método para isolar células trofoblásticas placentárias de células esfoliadas do colo do útero de uma mulher grávida

Info

Publication number
PT4144834T
PT4144834T PT228036141T PT22803614T PT4144834T PT 4144834 T PT4144834 T PT 4144834T PT 228036141 T PT228036141 T PT 228036141T PT 22803614 T PT22803614 T PT 22803614T PT 4144834 T PT4144834 T PT 4144834T
Authority
PT
Portugal
Prior art keywords
cells
pregnant woman
placental trophoblast
exfoliated cervical
separating
Prior art date
Application number
PT228036141T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Guangzhou Hybribio Medicine Tech Ltd
Guangdong Hybribio Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Hybribio Medicine Tech Ltd, Guangdong Hybribio Biotech Co Ltd filed Critical Guangzhou Hybribio Medicine Tech Ltd
Publication of PT4144834T publication Critical patent/PT4144834T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT228036141T 2021-05-20 2022-03-16 Método para isolar células trofoblásticas placentárias de células esfoliadas do colo do útero de uma mulher grávida PT4144834T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110549947.8A CN112980779B (zh) 2021-05-20 2021-05-20 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法

Publications (1)

Publication Number Publication Date
PT4144834T true PT4144834T (pt) 2024-12-26

Family

ID=76337075

Family Applications (1)

Application Number Title Priority Date Filing Date
PT228036141T PT4144834T (pt) 2021-05-20 2022-03-16 Método para isolar células trofoblásticas placentárias de células esfoliadas do colo do útero de uma mulher grávida

Country Status (11)

Country Link
US (1) US11796443B2 (cg-RX-API-DMAC7.html)
EP (1) EP4144834B9 (cg-RX-API-DMAC7.html)
JP (1) JP7368642B2 (cg-RX-API-DMAC7.html)
KR (1) KR102626620B1 (cg-RX-API-DMAC7.html)
CN (1) CN112980779B (cg-RX-API-DMAC7.html)
AU (1) AU2022277079B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022024743B1 (cg-RX-API-DMAC7.html)
ES (1) ES3007607T3 (cg-RX-API-DMAC7.html)
PL (1) PL4144834T3 (cg-RX-API-DMAC7.html)
PT (1) PT4144834T (cg-RX-API-DMAC7.html)
WO (1) WO2022242285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112980779B (zh) 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法
CN118957027A (zh) * 2024-10-17 2024-11-15 广州市刑事科学技术研究所 基于流式细胞分选实现男女混合生物检材的分型拆分方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447424B1 (en) * 1988-12-06 1998-01-07 Flinders Technologies Pty. Ltd. Isolation of fetal cells from maternal blood to enable prenatal diagnosis
WO1994002646A1 (en) * 1992-07-17 1994-02-03 Aprogenex Inc. Enriching and identyfying fetal cells in maternal blood for in situ hybridization
US5714325A (en) * 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
EP0819171A1 (en) * 1995-04-07 1998-01-21 The Regents Of The University Of California Antibodies for the detection of hla-g
US20020045196A1 (en) * 2000-05-12 2002-04-18 Walt Mahoney Methods of isolating trophoblast cells from maternal blood
AUPR749901A0 (en) * 2001-09-06 2001-09-27 Monash University Method of identifying chromosomal abnormalities and prenatal diagnosis
US20040197832A1 (en) * 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
WO2005047532A1 (en) * 2003-11-17 2005-05-26 Gribbles Molecular Science Pty Ltd Improved method of performing genetic analyses on reproductive tract cell samples
US20070224597A1 (en) * 2006-03-23 2007-09-27 Biocept, Inc. Isolating fetal trophoblasts
DE102007019017A1 (de) * 2007-04-19 2009-01-22 Ldt Laser Display Technology Gmbh Verfahren und Vorrichtung zum Projizieren eines Bildes auf eine Projektionsfläche
ITTO20070307A1 (it) * 2007-05-04 2008-11-05 Silicon Biosystems Spa Metodo e dispositivo per la diagnosi prenatale non-invasiva
US8674172B2 (en) * 2009-04-14 2014-03-18 Institut Gustave Roussy Prostate cancer cell lines and their use in screening method
AU2010239131A1 (en) * 2009-04-21 2011-11-17 Genetic Technologies Limited Methods for obtaining fetal genetic material
CN101726585A (zh) * 2009-11-30 2010-06-09 宁波普赛微流科技有限公司 一种基于微流控芯片的流式细胞仪
JP2015524054A (ja) * 2012-05-24 2015-08-20 ラールスル 濾過を通して生物学的サンプルから抽出された又は単離された希少細胞の多重分析のための方法
EP2909315B1 (en) * 2012-10-19 2019-05-01 Wayne State University Identification and analysis of fetal trophoblast cells in cervical mucus for prenatal diagnosis
CN103983794B (zh) * 2013-02-12 2016-06-15 李木 一种微流控芯片及一种微流控方法
WO2014201138A1 (en) * 2013-06-11 2014-12-18 Stelling James R Method for detection of fetal abnormalities
US10808239B2 (en) * 2016-04-06 2020-10-20 Wayne State University Isolation and analysis of fetal DNA from extravillous trophoblast cells retrieved from the endocervical canal
CN107312747A (zh) * 2016-12-20 2017-11-03 华东医药(杭州)基因科技有限公司 一种免疫磁珠法分离胎盘滋养层细胞的方法
CN108265051B (zh) * 2016-12-30 2020-08-25 张婧 用于从母体捕获和分离胎儿细胞的无创方法和试剂盒
WO2019153032A1 (en) * 2018-02-07 2019-08-15 University Of South Australia Pre-natal cell isolation
CN108535228B (zh) * 2018-04-03 2020-12-25 德运康明(厦门)生物科技有限公司 一种从孕妇外周血中分离游离胎儿细胞的方法
TWI668423B (zh) * 2018-10-02 2019-08-11 吳宏偉 細胞分選方法及系統
CN110117571B (zh) * 2019-05-08 2023-01-31 南方医科大学南方医院 无创获取胎儿稀有细胞的试剂盒及其方法
ES2955791T3 (es) * 2019-06-07 2023-12-07 Arcedi Biotech Aps Aislamiento de células fetales usando FACS
US20220235420A1 (en) * 2019-07-15 2022-07-28 Menarini Biomarkers Singapore Pte Ltd Compositions and methods for isolating, detecting, and analyzing fetal cells
CN111304153A (zh) * 2019-12-17 2020-06-19 广东凯普生物科技股份有限公司 一种分离滋养层细胞的方法
CN111440696B (zh) * 2020-02-26 2023-02-24 德运康明(厦门)生物科技有限公司 胎儿细胞捕获模块、用于胎儿细胞捕获的微流控芯片,及它们的使用方法
CN112980779B (zh) * 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法

Also Published As

Publication number Publication date
WO2022242285A1 (zh) 2022-11-24
CN112980779B (zh) 2021-08-24
KR102626620B1 (ko) 2024-01-17
KR20230004915A (ko) 2023-01-06
PL4144834T3 (pl) 2025-02-24
CN112980779A (zh) 2021-06-18
AU2022277079A1 (en) 2023-01-19
JP2023527246A (ja) 2023-06-27
US11796443B2 (en) 2023-10-24
EP4144834A4 (en) 2023-09-27
US20230228667A1 (en) 2023-07-20
ES3007607T3 (en) 2025-03-20
EP4144834A1 (en) 2023-03-08
EP4144834B1 (en) 2024-10-23
AU2022277079B2 (en) 2024-07-04
EP4144834B9 (en) 2024-12-18
JP7368642B2 (ja) 2023-10-24
BR112022024743A2 (cg-RX-API-DMAC7.html) 2023-06-27
BR112022024743B1 (pt) 2024-03-05

Similar Documents

Publication Publication Date Title
EP4144834A4 (en) METHOD FOR SEPARATING PLACENTAL TROPHOBLAST CELLS FROM EXFOLIATED CERVICAL CELLS OF PREGNANT WOMEN
WO2017176985A8 (en) Isolation and analysis of fetal dna from extravillous trophoblast cells retrieved from the endocervical canal
GB202117687D0 (en) Methods of rejuvenating aged tissue by inhibiting 15-hydroxyprostaglandin dehydrogenase (15-pgdh)
IL278160A (en) A device and process for producing a suitable tissue
EP4163384A4 (en) METHOD OF DETERMINING THE STATUS OF PREGNANCY PREGNANT
BR112021024474A2 (pt) Método de diagnóstico pré-natal
EA201791361A1 (ru) Терапия антагонистом рецепторов окситоцина в лютеиновую фазу для имплантации и беременности у женщин, проходящих процедуры вспомогательных репродуктивных технологий
HUE068560T2 (hu) Eljárás lítium dúsítására lítium agyag ércbõl
EP4301701A4 (en) PROCESS FOR PRODUCING ALUMINUM OXIDE
ES3065385T3 (en) Apparatus and method for preparation of electrode slurry
GB202103609D0 (en) Method of selecting cells
HUE073167T2 (hu) Eljárás anódzagy tulajdonságainak mérésére
GB202210963D0 (en) Methods for extraction and sequencing of nucleic acid
GB202109646D0 (en) Process for extraction of lithium from lithium-micas by calcination without ph adjustment
IL316709A (en) Methods for preparing lymphocytes for cell therapy
GB2613280B (en) Method for in vitro production of red blood cells
ZA202303949B (en) Method for preparing graphene oxide nanoscroll
EP4034302A4 (en) METHODS OF ISOLATION OF CELLS PRESENT IN PLACENTAL TISSUE
AU2024902470A0 (en) Process for digestion of aluminous ore
HK40091231A (en) Method for determining risk of pre-term birth
ZA202004199B (en) An apparatus for enhancing performance of an aluminium reduction cell in a smelting process
GB202313124D0 (en) Imaging for recognition of abnormalities
ZA202208356B (en) Artificial insemination method for improving conception rate of female donkey
CA3298904A1 (en) Method of synthesizing aluminum oxide from gallium-aluminum hydrogen evolution reaction
GB202409817D0 (en) Methods and compositions for trichome removal